Clinical Trial Update: A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update for Vedolizumab in adults with moderate to severe Crohn's disease; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Entyvio (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Crohn's Disease | Phase 3 | Status: RECRUITING